Skip to content

Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria

Adapting and Testing a Combination Peer Navigation and mHealth Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth in Nigeria

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06190613
Enrollment
110
Registered
2024-01-05
Start date
2024-11-28
Completion date
2026-12-31
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Brief summary

The study will adapt and test a combination peer navigation and mHealth approach, Intensive Combination Approach to Rollback the Epidemic in Nigeria (iCARE Nigeria), to improve HIV treatment engagement, medication adherence and viral suppression among YMSM and YTW, ages 15-29.

Detailed description

The study will adapt and test a combination peer navigation and mHealth approach, Intensive Combination Approach to Rollback the Epidemic in Nigeria (iCARE Nigeria), to improve HIV treatment engagement, medication adherence and viral suppression among young men who have sex with men (YMSM) and young transgender women (YTW), ages 15-29. The 24-week pilot study will randomize participants at a ratio of 1:1 to the intervention or control. The goals of the pilot study are to assess: a) whether the intervention worked as intended (initial efficacy); and b) the feasibility, satisfaction, and acceptability among the target population of YMSM and YTW receiving HIV care in the community setting. Specific aims are to: 1. Adapt the iCARE Nigeria HIV clinic-based intervention to a community-based outreach approach for YMSM and YTW ages 15-29 in Ibadan, Nigeria. This process will be structured using best practices for adaptation of evidence-based intervention, including distillation of adaptable components and incorporation of feedback from stakeholders, following user-centered principles of iterative design. 2. In a randomized controlled trial, test the adapted iCARE intervention for initial efficacy, feasibility, satisfaction, and acceptability among YMSM and YTW in the key population (KP)-focused community settings. The primary outcome will be viral load suppression (viral load\<200 copies/mL). Secondary outcomes include antiretroviral drug adherence, and treatment retention via abstraction of medical records. 3. Evaluate implementation indicators based on RE-AIM (reach, adoption, implementation, maintenance) to improve external validity and to inform sustainability and scalability of the adapted iCARE Nigeria intervention. A mixed methods approach will be used to collect data for implementation outcomes from interventionists, intervention participants, and representatives of KP-friendly community centers.

Interventions

BEHAVIORALCombination Peer navigation and mHealth intervention

Peer navigation and SMS text message medication reminders (adapted to YMSM and YTW in community outreach-based delivery approach)

Sponsors

Northwestern University
Lead SponsorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
15 Years to 29 Years
Healthy volunteers
No

Inclusion criteria

* HIV seropositive * registered as a patient at one of the collaborating key population (KP)-focused community centers * male sex at birth * identify as YMSM or YTW (or report a history of sex with men) * understand and read basic English, Yoruba, or Pidgin English * intention to remain a patient at a collaborating clinic during the 24-week follow-up period * has a cellphone

Exclusion criteria

* Unable to obtain parental permission if 15 years of age and not emancipated

Design outcomes

Primary

MeasureTime frameDescription
HIV viral load suppressionBaseline, 24 weeksViral load suppression (\<200 copies/mL) at baseline and 24 weeks

Secondary

MeasureTime frameDescription
Retention in HIV careBaseline, 24 weeksTwo medical visits in the 24-week study period, with a minimum of 60 days between visits
Medication adherenceBaseline, 24 weeksSelf-reported measure of adherence on visual analogue scale (0-100), with adherence measured as \>or = 90%
Feasibility of intervention24 weeksPhone-related and SMS text-related problems resulting in \<10% message failure, measured by text message platform administrative reports
Acceptability of intervention24 weeksAcceptability report of \>90% agreement based on Client Satisfaction Questionnaire-8 (CSQ-8)

Countries

Nigeria

Contacts

CONTACTLisa Kuhns, PhD
lkuhns@luriechildrens.org312-227-7760
PRINCIPAL_INVESTIGATORLisa Kuhns, PhD

Northwestern University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026